Dr. Mathur has over 10 years of experience as an economist in the areas of antitrust and competition, class certification, intellectual property, and general damages. She specializes in applying microeconomics, statistics, and econometrics to complex litigation matters, government and regulatory investigations, and consulting engagements. In the area of antitrust and competition, Dr. Mathur has worked on multiple joint conduct and unilateral conduct matters, including analysis of market definition, assessment of liability, and estimation of damages. She has worked on behalf of the US Department of Justice and the Federal Trade Commission, and consulted to firms in the pharmaceuticals industry at all stages of the distribution chain. Dr. Mathur has worked on behalf of pharmaceutical manufacturers in multiple cases related to claims of delayed entry of generic versions of brand drugs and allegations of reverse payments and product hopping. She has analyzed the impact of mergers in the pharmaceutical industry; analyzed competition issues related to steering, tiering, and related contractual provisions; and assessed damages and lost profits in breach of contract disputes between manufacturers, wholesalers, and distributors.